[Some problems posed by double-blind investigation of psychotropic drugs: clinical trial of Nobrium Roche].
D000553:Ambulatory Care; D001008:Anxiety Disorders / Q000188:drug therapy; D001291:Attitude of Health Personnel; D002986:Clinical Trials as Topic; D003291:Conversion Disorder / Q000188:drug therapy; D004358:Drug Therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D008722:Methods; D010551:Personality; D010817:Physician-Patient Relations; D010919:Placebos; D011600:Psychopharmacology; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D013223:Statistics as Topic; D014149:Tranquilizing Agents / Q000627:therapeutic use
D010919:Placebos; D014149:Tranquilizing Agents
Quelques problèmes posés par l'expérimentation à double insu de médicaments psychotropes: à propos de l'essai du Nobrium Roche.